Zobrazeno 1 - 10
of 52
pro vyhledávání: '"M J Gill"'
Autor:
Z Lee, S Nishikawa, S Gao, J B Eksteen, M Czub, M J Gill, C Osiowy, F van der Meer, G van Marle, C S Coffin
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137568 (2015)
The hepatitis B virus (HBV) and the human immunodeficiency virus type 1 (HIV-1) can infect cells of the lymphatic system. It is unknown whether HIV-1 co-infection impacts infection of peripheral blood mononuclear cell (PBMC) subsets by the HBV.To com
Externí odkaz:
https://doaj.org/article/4074bad5c7ac42d094230908b6fc62b9
Publikováno v:
Epidemiology and Infection
Antibiotic-resistant Gram-negative bacteraemias (GNB) are increasing in incidence. We aimed to investigate the impact of empirical antibiotic therapy on clinical outcomes by carrying out an observational 6-year cohort study of patients at a teaching
Autor:
H B, Krentz, M J, Gill
Publikováno v:
HIV medicine. 16(1)
Improved survival has shifted the HIV epidemic in the developed world towards more individuals50 years of age. Older individuals, with new or longstanding HIV infection, are at greater risk for HIV-related and non-HIV-related conditions, compounding
Autor:
M Power, David A. Cooper, J. Fry, William G. Powderly, Fiona Holland, Fred R. Sattler, Gary N. Holland, Judith Feinberg, Richard B. Pollard, Susan Owens, Shelley Hurwitz, Mark A. Jacobson, Paul D. Griffiths, Rob Roy MacGregor, M Youle, D Coakley, M J Gill
Publikováno v:
The Journal of Infectious Diseases. 177:48-56
Cytomegalovirus (CMV) disease is a common complication of advanced human immunodeficiency virus (HIV) infection. Administration of oral valaciclovir, a valine ester of acyclovir, achieves sufficient plasma acyclovir levels to inhibit many clinical is
Publikováno v:
Journal of Antimicrobial Chemotherapy. 37:825-829
Zidovudine absorption was evaluated in HIV seropositive patients with (n = 15) and without diarrhoea (n = 20) in a standardised prospective pharmacokinetic study using single oral 200 mg doses. Zidovudine was rapidly absorbed with large peak variatio
Publikováno v:
HIV medicine. 14(5)
Intimate partner violence (IPV) is a risk factor for HIV infection. Little is known, however, about the prevalence, clinical associations, and impact of IPV among patients living with HIV.HIV-infected gay and bisexual men in Southern Alberta, Canada
Publikováno v:
HIV medicine. 14(2)
The aim of the study was to determine the risk factors predictive of symptomatic HIV-associated neurocognitive disorders (sHAND) among HIV-infected patients receiving active medical care.Baseline demographic and clinical characteristics were analysed
Autor:
M, Murray, R S, Hogg, V D, Lima, M T, May, D M, Moore, S, Abgrall, M, Bruyand, A, D'Arminio Monforte, C, Tural, M J, Gill, R J, Harris, P, Reiss, A, Justice, O, Kirk, M, Saag, C J, Smith, R, Weber, J, Rockstroh, P, Khaykin, J A C, Sterne
Publikováno v:
HIV medicine. 13(2)
We examined whether determinants of disease progression and causes of death differ between injecting drug users (IDUs) and non-IDUs who initiate combination antiretroviral therapy (cART).The ART Cohort Collaboration combines data from participating c
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 21
Management of febrile neutropenia: ESMO Clinical Practice Guidelines J. de Naurois, I. Novitzky-Basso, M. J. Gill, F. Marti Marti, M. H. Cullen & F. Roila On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology; Department of H
Autor:
M J, Gill
Publikováno v:
Renaissance quarterly. 54(2)